Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefazodone in Cocaine Dependent Subjects
NCT00015210Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Feb 1997
- Primary completion
- May 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence and major depressive disorder (MDD) comparing Nefazodone with Placebo (2 arms). Primary endpoint: Urine benzoylecgonine (BE) concentration. Started Feb 1997; status: completed.
02
Drugs
nefazodone
03
Conditions
cocaine dependencemajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00015210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015210.